Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

More precise, personalized therapies are needed for autoimmune diseases.

Fibroblast Growth Factor-9 (FGF-9) can help improve heart function in diabetic mice after a heart attack by reducing inflammation and harmful changes to the heart's structure.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Hair follicle and adipose cell vesicles both protect neurons and reduce inflammation similarly.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Interleukin-1 increases keratin K6 production in skin cells.

The study found key genes and pathways involved in cashmere goat hair growth stages.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Scientists now better understand how human hair growth is controlled, including the roles of specific genes and proteins.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

HYDRO DELUXE BIO hyaluronic acid hydrogel is compatible with skin cells, may reduce inflammation, promote blood vessel growth, and protect against oxidative stress, suggesting it could help revitalize hair follicles.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

BLH308, made from persimmon leaf, green tea, and sophora fruit, may help reduce hair loss by fighting oxidative stress and inflammation.

Facial hidradenitis suppurativa can be mistaken for acne but requires different treatment.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Some drugs for inflammation may cause psoriasis-like hair loss.